A Study of Tarlatamab for People With Prostate Cancer

NCT07111507 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Prostate Cancer

Interventions

DRUG: Tarlatamab

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]